<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Primrose Surgery</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Primrose Surgery is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=1104020Y0&amp;denomIds=11.4.2&amp;selectedTab=summary">Ketotifen fumarate</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>8</td>
      <td>Other anti-inflammatory preparations</td>
      <td>45</td>
      <td>0.18</td>
      <td>0.02</td>
      <td>0.04</td>
      <td>4.49</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=1104020Y0BBAAAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Zaditen 250micrograms/ml eye drops : 8</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=1001010AH&amp;denomIds=10.1.1&amp;selectedTab=summary">Celecoxib</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>119</td>
      <td>Non-steroidal anti-inflammatory drugs</td>
      <td>629</td>
      <td>0.19</td>
      <td>0.03</td>
      <td>0.04</td>
      <td>4.39</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=1001010AHAAAAAA&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Celecoxib 100mg capsules : 66</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=1001010AHAAABAB&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Celecoxib 200mg capsules : 46</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=1001010AHBBAAAA&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Celebrex 100mg capsules : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=1001010AHBBABAB&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Celebrex 200mg capsules : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0406000AA&amp;denomIds=4.6&amp;selectedTab=summary">Doxylamine succinate/pyridoxine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>9</td>
      <td>Drugs used in nausea and vertigo</td>
      <td>376</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>4.31</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0406000AAAAABAB&amp;denomIds=4.6&amp;selectedTab=summary" target="_blank">Doxylamine 10mg / Pyridoxine 10mg gastro-resistant tablets : 9</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0301011U0&amp;denomIds=3.1.1&amp;selectedTab=summary">Salmeterol</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>68</td>
      <td>Selective beta(2)-agonists</td>
      <td>1241</td>
      <td>0.05</td>
      <td>0.01</td>
      <td>0.01</td>
      <td>3.93</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0301011U0BBAEAE&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Serevent 50micrograms/dose Accuhaler : 35</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0301011U0AAAEAE&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salmeterol 50micrograms/dose dry powder inhaler : 22</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0301011U0AAAHAH&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salmeterol 25micrograms/dose inhaler CFC free : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0301011U0BBAFAH&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Serevent 25micrograms/dose Evohaler : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0302000R0&amp;denomIds=3.2&amp;selectedTab=summary">Mometasone furoate</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Corticosteroids (respiratory)</td>
      <td>1428</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>3.92</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0302000R0AAACAC&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Mometasone 400micrograms/dose dry powder inhaler : 4</a></div></td></tr></tbody></table>

        <h2>Prescribing where Primrose Surgery is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0205040D0&amp;denomIds=2.5.4&amp;selectedTab=summary">Doxazosin mesilate</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>405</td>
      <td>Alpha-adrenoceptor blocking drugs</td>
      <td>426</td>
      <td>0.95</td>
      <td>0.99</td>
      <td>0.02</td>
      <td>-2.02</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0205040D0AAAAAA&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 1mg tablets : 86</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0205040D0AAABAB&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 2mg tablets : 106</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0205040D0AAACAC&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 4mg tablets : 167</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0205040D0AAAQAQ&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 4mg modified-release tablets : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0205040D0AAARAR&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 8mg modified-release tablets : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0205040D0AABBBB&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 8mg tablets : 23</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0703050A0&amp;denomIds=7.3.5&amp;selectedTab=summary">Levonorgestrel</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Emergency contraception</td>
      <td>2</td>
      <td>0.00</td>
      <td>0.62</td>
      <td>0.33</td>
      <td>-1.87</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=0501090R0&amp;denomIds=5.1.9&amp;selectedTab=summary">Rifampicin</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Antituberculosis drugs</td>
      <td>6</td>
      <td>0.00</td>
      <td>0.73</td>
      <td>0.40</td>
      <td>-1.81</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=1202020L0&amp;denomIds=12.2.2&amp;selectedTab=summary">Sodium chloride</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Topical nasal decongestants</td>
      <td>11</td>
      <td>0.00</td>
      <td>0.54</td>
      <td>0.31</td>
      <td>-1.72</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=040201060&amp;denomIds=4.2.1&amp;selectedTab=summary">Olanzapine</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>51</td>
      <td>Antipsychotic drugs</td>
      <td>646</td>
      <td>0.08</td>
      <td>0.23</td>
      <td>0.09</td>
      <td>-1.62</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=040201060AAACAC&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Olanzapine 10mg tablets : 29</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=040201060AAALAL&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Olanzapine 15mg tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=040201060AAAQAQ&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Olanzapine 20mg tablets : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=040201060AAADAD&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Olanzapine 2.5mg tablets : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P91012&amp;numIds=040201060AAAAAA&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Olanzapine 5mg tablets : 10</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>